Panteion University of Social and Political Sciences
Η εφαρμογή της αναπτυξιακής στρατηγικής στο σύγχρονο ελληνικό πολιτικό περιβάλλον: η περίπτωση του κλάδου υγείας
Abstract
dc:descriptionThe global financial crisis has led many governments to shrink their health budget, compromising the efficiency, innovation and quality of the health services provided. To effectively address this issue, the development of new strategies is essential to ensure sustainable growth in the key health sector. Given the pivotal role of medicines and medical devices in health promotion, this dissertation aims to study the field of “health technology assessment” at a European level, as well as describe the current state of supply of medical devices and the ongoing assessment and reimbursement of medicines at a national level. Based on our findings, a prospective model of supply and reimbursement was proposed as eligible for implementation in our country, to enhance the quality, efficiency and sustainability of our national health system. The present dissertation is based on two main concepts: a) the principle of "value-based procurement" regarding the supply of medical devices and b) “health technology assessment”, referring both to the supply of medical devices and to drug reimbursement. The approach of “value-based procurement” focuses on the purchase of medical technology based on its overall long-term value, rather than its upfront cost, thus paving the way for the improvement of patient outcomes and/or cost reduction in care delivery. The notion of value combines enhanced results and greater patient satisfaction with safer, innovative, more qualitative, eco-friendly and user-friendly products. Health Technology Assessment (HTA) is the process of scientific evaluation of a new technology, assessing its quality, safety, efficiency and cost-effectiveness, as well as the socio-ethical, legal and organizational implications of its use and diffusion. The purpose of HTA is to encourage the use of technologies that promote health in a safer, more efficient and effective manner, and prevent the use of less effective technologies. HTA helps policy makers develop effective interventions in the health sector, while reinforcing the sustainability of national health systems. With regard to medical devices, the present study showed that “value based procurement” (VBP) contributes to a more efficient, innovative, human-centered and sustainable health system. The fruitful implementation of this principle in the field of medical device supply calls for the design of an organized and holistic development strategy. Regarding medical devices, this doctoral dissertation proposes: Firstly, to assess the necessity of medical devices (needs assessment|) in healthcare units. Secondly, to evaluate daily practice data (micro-valuation of medical equipment / Medical Equipment Vigilance), deriving from the use of existing medical equipment. Thirdly, to analyze micro-valuation data and transfer them to a national central body of Health Technology Assessment (HTA), the establishment of which is deemed necessary. The competent Directorate of the national HTA body will be responsible for studying individual reports and forming a comprehensive assessment report for each product. These reports will be sent to the competent procurement bodies to be considered when formulating the Hospital Procurement Program. The Organization will also have a Medical Technology Assessment Department to evaluate new / innovative medical devices.Regarding drug reimbursement, EU countries set a precedent, necessitating the inclusion of both medicine and medical device assessment in the jurisdiction of our national Public Health Technology Assessment Organization (HTA). Within the operational framework of this Organization, medicinal products will be assessed in terms of their therapeutic value and safety, while at the same time, ethical, social, organizational and legal issues related to their use will also be reckoned with. Subsequently, HTA will be used to determine reimbursement decisions on pharmaceuticals. The findings that emerged highlight the inadequacy of current national practices in medical device supply and drug reimbursement to enhance the Greek healthcare system. Significant changes need to be made based on the principles of value-based procurement for medical devices and health technology assessment for both pharmaceuticals and medical devices. All things considered, it is proposed to formulate an integrated development strategy, to prevent unnecessary health expenses and optimize the use of our limited resources, while providing patients with safe, qualitative, efficient and innovative health technologies, without however threatening the viability of the national health system.
Degree
thesis:*- Grantor dc:publisher
- Panteion University of Social and Political Sciences
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikolopoulou, Vasiliki
- Νικολοπούλου, Βασιλική
Subjects
dc:subject × 16- Απόδοση αξίας στο σύστημα υγείας
- Αξιολόγηση τεχνολογιών υγείας
- Φάρμακα
- Ιατροτεχνολογικά προϊόντα
- Σύστημα αποζημίωσης
- Value-based procurement
- Health technology assessment
- Pharmaceuticals
- Medical devices
- Reimbursement system
- Πολιτικές Επιστήμες
- Κοινωνικές Επιστήμες
- Δημόσια διοίκηση
- Political Science
- Social Sciences
- Public Administration
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48999